Free Trial

Raymond James Financial Inc. Purchases Shares of 52,948 Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare logo with Medical background
Remove Ads

Raymond James Financial Inc. purchased a new stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 52,948 shares of the company's stock, valued at approximately $6,637,000. Raymond James Financial Inc. owned about 0.29% of Addus HomeCare as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Quarry LP purchased a new position in Addus HomeCare during the 3rd quarter valued at about $28,000. Smartleaf Asset Management LLC grew its holdings in shares of Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after purchasing an additional 214 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after buying an additional 148 shares during the period. KBC Group NV lifted its holdings in Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after buying an additional 268 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in Addus HomeCare by 34.5% in the 4th quarter. GAMMA Investing LLC now owns 1,258 shares of the company's stock valued at $158,000 after buying an additional 323 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Stock Up 1.7 %

Shares of NASDAQ ADUS traded up $1.65 during mid-day trading on Thursday, hitting $97.80. 227,883 shares of the company were exchanged, compared to its average volume of 150,038. The stock has a 50 day simple moving average of $109.75 and a 200-day simple moving average of $121.08. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72. The firm has a market cap of $1.78 billion, a price-to-earnings ratio of 22.38, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97.

Remove Ads

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to analysts' expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Analyst Ratings Changes

ADUS has been the topic of a number of analyst reports. Oppenheimer raised their price target on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. JMP Securities assumed coverage on Addus HomeCare in a report on Monday, December 16th. They issued an "outperform" rating and a $150.00 price target for the company. Stephens reissued an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, Citizens Jmp raised shares of Addus HomeCare to a "strong-buy" rating in a research report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $132.78.

View Our Latest Stock Analysis on ADUS

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 4.60% of the stock is owned by corporate insiders.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads